The Werribee News comprehensive investigation into Australia’s rapidly expanding online testosterone replacement therapy (TRT) industry has uncovered concerning practices that may be putting men’s health at risk while extracting hundreds of dollars from patients who may not require treatment.
The investigation, spanning two months and involving interviews with medical professionals, patients, and industry insiders, reveals a system where profit appears to take precedence over proper medical care, with some clinics charging up to $600 for consultations and tests that are available free through Australia’s Medicare system.
The Booming Testosterone Replacement Therapy (TRT) Industry
The testosterone replacement therapy market in Australia has experienced explosive growth over the past five years.
Research published in the Australian Journal of General Practice found 105,429 men, 2.9 out of every 1,000 men had initiated TRT in a two-year period, but industry sources suggest this figure has increased dramatically since the emergence of online clinics.
Multiple online TRT clinics now operate across Australia, with some claiming to treat thousands of patients. Enhanced Men’s Clinic, one of the leading providers, advertises having over 2,500 patients, while numerous other clinics have emerged to capitalise on growing demand.
The Cost Disparity: Medicare vs. Private Clinics
The most striking aspect of the investigation is the dramatic cost difference between seeking treatment through Australia’s public health system versus private online clinics.
Private Online Clinic Costs:
- Initial consultation: $250-$300
- Blood tests: $75 each (typically requiring 2-3 tests)
- Prescription medications: $50-$150 per month
- Total initial cost: $450-$600+ before medication
Medicare-Covered Alternative:
- GP consultation: Free under Medicare
- Blood tests: Free under Medicare if clinically indicated
- Prescription medication: $75 (private script) if clinically justified
- Total cost: $75 if genuine clinical need exists
This represents a cost difference of up to 800% for identical diagnostic procedures and treatments.
Normal Testosterone Levels: The Gray Area Exploited
Central to the overprescribing issue is the manipulation of testosterone reference ranges and the failure to properly explain what constitutes “normal” testosterone levels.
Australian research on healthy men aged 21-35 established a reference range of 9.7-34.3 nmol/L with a mean of 18.2 nmol/L.
However, different medical societies recommend varying thresholds, with some suggesting men with levels below 8 nmol/L may benefit from supplementation, while others recommend 9.8-10.4 nmol/L as the lower limit.
This variation in guidelines creates an opportunity for less scrupulous clinics to justify treatment for men whose testosterone levels may be perfectly normal for their individual physiology.
The Individual Variation Factor
Medical experts advise that testosterone levels vary significantly between individuals, and what’s “normal” for one man may be low for another.
Recent research emphasises that if a man doesn’t exhibit symptoms typically associated with low testosterone, his lower level might still be perfectly normal for him.
Medical professionals emphasize that testosterone levels of 12-15 nmol/L are frequently within the normal range for many men, yet some clinics market these as requiring treatment. The clinical focus should be on symptoms and overall health assessment, not solely on laboratory values.
The Symptom Checklist Problem
Online TRT clinics typically use extensive symptom checklists that include common, non-specific complaints such as:
- Fatigue
- Reduced motivation
- Difficulty concentrating
- Mood changes
- Decreased muscle mass
- Reduced libido
These symptoms are experienced by millions of Australian men and can be caused by numerous factors including:
- Sleep disorders (affecting 40% of Australian adults)
- Stress and anxiety (affecting 25% of Australian men)
- Depression (affecting 12% of Australian men annually)
- Obesity (affecting 67% of Australian men)
- Diabetes (affecting 8% of Australian men)
- Cardiovascular disease
- Thyroid disorders
- Nutritional deficiencies
The Problem of Misdiagnosis
Medical professionals report seeing increasing numbers of men who have been prescribed testosterone replacement therapy despite having normal testosterone levels or underlying conditions that could explain their symptoms.
The pattern of misdiagnosis often involves men with testosterone levels between 12-16 nmol/L – well within normal ranges – being told they have “suboptimal” or “low normal” testosterone requiring treatment.
Sleep disorders, which affect 40% of Australian adults, are frequently overlooked as a primary cause of fatigue and reduced motivation.
Similarly, depression affecting 12% of Australian men annually, and anxiety disorders affecting 25% of Australian men, can present with symptoms identical to those attributed to low testosterone.
The Hidden Risks Not Explained
Online TRT clinics often downplay or fail to adequately explain the potential risks of testosterone replacement therapy, which include:
Cardiovascular Risks
- Increased risk of heart attack and stroke
- Elevated blood pressure
- Increased hematocrit (blood thickness)
- Potential for blood clots
Reproductive Health Impact
- Suppression of natural testosterone production
- Testicular atrophy
- Reduced sperm count and fertility
- Potential permanent damage to natural hormone production
Other Serious Risks
- Prostate enlargement
- Increased risk of prostate cancer
- Liver toxicity (with oral formulations)
- Mood changes and aggression
- Acne and skin changes
- Sleep apnea exacerbation
The Dependency Issue
One of the most concerning aspects rarely discussed is the potential for long-term dependency. Once men begin TRT, their natural testosterone production is suppressed through negative feedback loops.
Stopping treatment can result in:
- Severely low testosterone levels
- Depression and mood changes
- Extreme fatigue
- Loss of muscle mass
- Reduced sexual function
This creates a situation where men may become dependent on ongoing treatment, ensuring continued revenue for clinics.
The Regulatory Gap
Australia’s Therapeutic Goods Administration (TGA) regulates testosterone medications, but the oversight of prescribing practices falls to state medical boards and individual practitioners. This creates a regulatory gap that some clinics exploit.
Former TGA advisors note that while testosterone medications are approved and regulated, the oversight of prescribing practices falls to state medical boards and individual practitioners.
This creates a regulatory gap that can be exploited by clinics operating in commercial rather than clinical frameworks.
The Australian Health Practitioner Regulation Agency (AHPRA) has received complaints about TRT prescribing practices, but enforcement action has been limited.
The Marketing Machine
Online TRT clinics invest heavily in marketing, using social media, search engine optimization, and targeted advertising to reach potential patients.
Marketing materials often emphasise benefits while minimizing discussion of risks or alternative diagnoses. The approach can create unrealistic expectations about treatment outcomes and may not adequately inform patients about the complexity of hormone replacement therapy.
The Telemedicine Loophole
The rise of telemedicine, accelerated by the COVID-19 pandemic, has created new opportunities for TRT clinics to operate across state boundaries with minimal oversight.
Many clinics conduct “consultations” via video calls lasting 15-30 minutes, often using questionnaires that can be completed in advance. This abbreviated assessment process may not allow for proper evaluation of symptoms or consideration of alternative diagnoses.
What Proper TRT Assessment Should Include
Medical experts agree that proper testosterone deficiency assessment should include:
Comprehensive Medical History
- Detailed symptom assessment
- Family history
- Medication review
- Assessment of other medical conditions
Physical Examination
- Blood pressure and cardiovascular assessment
- Prostate examination
- Assessment of secondary sexual characteristics
- Body composition evaluation
Laboratory Testing
- Multiple testosterone measurements (levels can vary significantly)
- Morning samples (testosterone is highest in early morning)
- Total and free testosterone
- Luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
- Prolactin levels
- Thyroid function tests
- Complete blood count
- Lipid profile
- Liver function tests
- Prostate-specific antigen (PSA)
Exclusion of Other Conditions
- Sleep disorders
- Depression and anxiety
- Diabetes
- Thyroid disorders
- Obesity
- Cardiovascular disease
- Pituitary disorders
The Economic Impact
The growth of the online TRT industry represents a significant economic phenomenon, with some estimates suggesting the market is worth over $50 million annually in Australia.
This money is largely flowing from patients’ pockets to private clinics, rather than being invested in public health infrastructure or preventive care that might address the root causes of symptoms.
Professional Medical Opinion
The Endocrine Society of Australia has expressed concern about the commercialization of testosterone therapy, noting that many men being treated don’t meet the clinical criteria for testosterone deficiency. The long-term consequences of unnecessary treatment are not being adequately considered in many commercial settings.
The Royal Australian College of General Practitioners (RACGP) has also expressed concern about overprescribing trends, emphasizing the importance of proper assessment and the consideration of alternative diagnoses before initiating testosterone therapy.
International Perspective
Australia’s situation mirrors trends seen in other countries, particularly the United States, where the TRT market has exploded over the past decade. Regulatory authorities in several countries have issued warnings about overprescribing and inappropriate marketing of testosterone products.
The Path Forward
Regulatory Reform
- Stricter oversight of telemedicine prescribing
- Mandatory reporting of testosterone prescriptions
- Enhanced penalties for inappropriate prescribing
Professional Education
- Updated guidelines for testosterone deficiency diagnosis
- Continuing medical education requirements
- Standardised assessment protocols
Public Education
- Awareness campaigns about normal testosterone variation
- Information about alternative causes of symptoms
- Clear communication about treatment risks
Healthcare System Changes
- Improved access to endocrinology services
- Better integration of mental health and sleep medicine
- Enhanced GP education about testosterone assessment
Consumer Protection Measures
Red Flags for Patients
Men considering TRT should be wary of:
- Clinics that guarantee specific outcomes
- Providers who don’t require comprehensive testing
- Consultations that last less than 30 minutes
- Clinics that don’t discuss risks or alternatives
- Providers who pressure for immediate treatment decisions
Questions to Ask
- What are my actual testosterone levels and how do they compare to reference ranges?
- Have other potential causes of my symptoms been considered?
- What are the risks and side effects of treatment?
- What happens if I want to stop treatment?
- Are there alternative treatments I should consider first?
The Real Cost of Overtreating
Beyond the financial cost, the overprescribing of testosterone carries significant health and social costs:
Health Consequences
- Unnecessary exposure to medication risks
- Delayed diagnosis of underlying conditions
- Potential long-term hormone system damage
- Increased healthcare utilisation for side effects
Social Impact
- Erosion of trust in healthcare system
- Normalisation of performance enhancement drugs
- Perpetuation of unrealistic masculinity expectations
- Diversion of resources from genuine medical needs
Online TRT Conclusion
- This investigation reveals a concerning pattern of profit-driven medicine in Australia’s online TRT industry.
- While legitimate testosterone deficiency exists and requires treatment, the evidence suggests that many men are being prescribed testosterone unnecessarily, at significant personal cost and potential health risk.
- The dramatic cost difference between private clinics and Medicare-covered care highlights the need for better patient education about healthcare options.
- Many men could receive appropriate assessment and treatment through the public health system at a fraction of the cost.



